The World Trade Organization (WTO), World Health Organization (WHO) and World Intellectual Property Organization (WIPO) have issued the second edition of a trilateral study that aims to build understanding of the interplay between the policy domains of health, trade, and intellectual property (IP), and their impacts on medical innovation and access to medical technologies.

The study presents new data on health, innovation trends in the pharmaceutical sector, and trade and tariffs relating to medical products, capturing insights from joint technical assistance activities and taking into account developments in intellectual property legislation and jurisprudence.


Be the first one to comment

Please log in or sign up to comment.